BeneVir Biopharm

Bene Vir Biopharm

Biotechnology, 1330 Piccard Dr Ste 101, Rockville, Maryland, 20850, United States, 11-50 Employees

benevir.com

  • twitter
  • LinkedIn

phone no Phone Number: +12*********

Who is BENEVIR BIOPHARM

ONCOLYTIC IMMUNOTHERAPY Immunotherapies are an exciting new class of therapies that utilize the immune system to attack and kill cancer cells. One type of immunotherapy is the oncolytic v...

Read More

map
  • 1330 Piccard Dr Ste 101, Rockville, Maryland, 20850, United States Headquarters: 1330 Piccard Dr Ste 101, Rockville, Maryland, 20850, United States
  • 2011 Date Founded: 2011
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from BENEVIR BIOPHARM

BeneVir Biopharm Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding BeneVir Biopharm

Answer: BeneVir Biopharm's headquarters are located at 1330 Piccard Dr Ste 101, Rockville, Maryland, 20850, United States

Answer: BeneVir Biopharm's phone number is +12*********

Answer: BeneVir Biopharm's official website is https://benevir.com

Answer: BeneVir Biopharm's revenue is Under $1 Million

Answer: BeneVir Biopharm's SIC: 8731

Answer: BeneVir Biopharm has 11-50 employees

Answer: BeneVir Biopharm is in Biotechnology

Answer: BeneVir Biopharm contact info: Phone number: +12********* Website: https://benevir.com

Answer: ONCOLYTIC IMMUNOTHERAPY Immunotherapies are an exciting new class of therapies that utilize the immune system to attack and kill cancer cells. One type of immunotherapy is the oncolytic virus, which is a virus designed to specifically infect and destroy cancer cells. In addition to directly killing cancer cells, the most effective oncolytic viruses also stimulate the immune system to find and destroy cancer throughout the body. BENEVIRS BREAKTHROUGH TECHNOLOGY The BeneVir oncolytic virus platform is based on T-Stealth technology, which overcomes a major barrier to the clinical success of oncolytic viruses. This barrier is the bodys immune system, which is very effective at killing both harmful viruses (like flu) and beneficial viruses (like oncolytic viruses). BeneVirs T-Stealth oncolytic viruses hide from the immune system in order to continue to destroy cancer cells, both directly and through activation of the immune system.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access